Cumberland Partners Ltd Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cumberland Partners Ltd lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 35,030 shares of the healthcare conglomerate's stock after selling 25,944 shares during the quarter. UnitedHealth Group comprises 1.2% of Cumberland Partners Ltd's holdings, making the stock its 27th biggest position. Cumberland Partners Ltd's holdings in UnitedHealth Group were worth $17,720,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Parthenon LLC increased its holdings in UnitedHealth Group by 12.3% in the 4th quarter. Parthenon LLC now owns 546 shares of the healthcare conglomerate's stock worth $276,000 after purchasing an additional 60 shares in the last quarter. Financial Perspectives Inc raised its position in shares of UnitedHealth Group by 7.2% in the 4th quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate's stock worth $2,256,000 after acquiring an additional 300 shares in the last quarter. Alberta Investment Management Corp grew its position in shares of UnitedHealth Group by 211.4% during the 4th quarter. Alberta Investment Management Corp now owns 24,915 shares of the healthcare conglomerate's stock worth $12,604,000 after buying an additional 16,915 shares during the period. Summit Place Financial Advisors LLC increased its stake in UnitedHealth Group by 5.1% in the fourth quarter. Summit Place Financial Advisors LLC now owns 5,162 shares of the healthcare conglomerate's stock valued at $2,611,000 after purchasing an additional 249 shares in the last quarter. Finally, Vista Capital Partners Inc. boosted its holdings in UnitedHealth Group by 19.3% in the fourth quarter. Vista Capital Partners Inc. now owns 737 shares of the healthcare conglomerate's stock worth $373,000 after acquiring an additional 119 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on UNH shares. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. KeyCorp reissued an "overweight" rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Truist Financial cut their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $629.32.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 7.1 %

Shares of UNH stock traded down $35.87 during mid-day trading on Friday, hitting $466.55. The company's stock had a trading volume of 16,946,496 shares, compared to its average volume of 4,697,853. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The business has a 50-day moving average price of $520.37 and a 200 day moving average price of $561.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $429.35 billion, a price-to-earnings ratio of 30.09, a PEG ratio of 1.40 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the company earned $5.83 earnings per share. The business's revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.